WST Stock Fair Value Calculator – West Pharmaceutical Services Stock Skyrockets Friday, Outperforming Market
December 2, 2023
🌥️Trending News
Friday was a big day for West Pharmaceutical Services ($NYSE:WST) Inc. The stock experienced a significant increase, outperforming the market as a whole. West Pharmaceutical Services Inc. is a leading provider of pharmaceutical packaging and delivery systems for the global healthcare industry. It manufactures a variety of products including elastomeric components, prefillable syringes, drug delivery systems, and components for medical devices. The company has a long history of innovation and is well-known for developing safety measures in the pharmaceutical industry. Its products are used in the production of injectable drugs and medical devices worldwide, and it has become a leader in the pharmaceuticals packaging market due to its commitment to quality and customer service.
The increase in West Pharmaceutical Services Inc. stock on Friday is due to the company’s strong performance and its continued success in the industry. Investors have been attracted to its diverse product portfolio and its focus on safety and customer satisfaction. West Pharmaceutical Services Inc. also recently announced a new initiative to expand its presence globally, which is likely to result in further success for the company and its shareholders.
Share Price
On Monday, WEST PHARMACEUTICAL SERVICES opened at $352.1 and closed at $353.9, a 0.2% increase from its previous closing price of 353.3. Investors responded positively to WEST PHARMACEUTICAL SERVICES’ high-performing stock, signaling an overall confidence in the company’s financial future. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for WST. More…
| Total Revenues | Net Income | Net Margin |
| 2.93k | 559.4 | 20.5% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for WST. More…
| Operations | Investing | Financing |
| 768.2 | -354.7 | -279.6 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for WST. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 3.75k | 886.5 | 38.76 |
Key Ratios Snapshot
Some of the financial key ratios for WST are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 12.8% | 22.9% | 22.8% |
| FCF Margin | ROE | ROA |
| 14.4% | 14.9% | 11.1% |
Analysis – WST Stock Fair Value Calculator
At GoodWhale, we are committed to providing our users with comprehensive financial analysis of companies. We recently conducted an analysis of WEST PHARMACEUTICAL SERVICES, and our results indicate that the fair value of the company’s stock is around $360.1. This was calculated using our proprietary Valuation Line, which takes into consideration various factors such as financial reports, competitive landscape, and market trends. Currently, WEST PHARMACEUTICAL SERVICES stock is traded at $353.9, a fair price that is undervalued by 1.7%. Our analysis provides investors with an insightful look at the company’s overall performance and stock valuation. More…
Peers
The company operates in North America, Europe, Asia, and South America. Seikagaku Corp, Shenyang Xingqi Pharmaceutical Co Ltd, and Shenzhen Salubris Pharmaceuticals Co Ltd are all competitors of West Pharmaceutical Services Inc.
– Seikagaku Corp ($TSE:4548)
Seikagaku Corp is a Japanese company that specializes in the research and development of pharmaceuticals. The company has a market cap of 53.35B as of 2022 and a return on equity of 2.38%. Seikagaku Corp’s products include treatments for osteoarthritis, inflammatory diseases, and cancer.
– Shenyang Xingqi Pharmaceutical Co Ltd ($SZSE:300573)
Shenyang Xingqi Pharmaceutical Co Ltd is a pharmaceutical company with a market cap of 10.63B as of 2022. The company has a return on equity of 12.24%. The company’s main products are traditional Chinese medicines and western medicines. The company also has a research and development center which is responsible for the development of new products and the improvement of existing products. The company has a strong marketing network and a good reputation in the industry.
– Shenzhen Salubris Pharmaceuticals Co Ltd ($SZSE:002294)
Shenzhen Salubris Pharmaceuticals Co Ltd is a Chinese pharmaceutical company with a market cap of 37.86B as of 2022. The company’s ROE is 6.05%. Shenzhen Salubris Pharmaceuticals Co Ltd is engaged in the research, development, manufacture and sale of pharmaceutical products. The company’s products include drugs for the treatment of cardiovascular and cerebrovascular diseases, cancer, infections, digestive diseases and other diseases.
Summary
West Pharmaceutical Services, Inc. had a strong day on Friday, outperforming the market as the stock rose significantly. Analysts credit investments in research and development, as well as strong financial performance, for the positive performance. The company has placed its focus in the pharmaceutical industry, and is currently benefiting from the increase in demand for new products.
The company has also benefited from the acquisition of several new technologies, which have helped to bolster its product portfolio. Investors are expecting West Pharmaceutical Services to continue to thrive in the future as it seeks out new opportunities to expand its global reach and provide quality services.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
